Centerpoint Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $171K | Hold |
4,000
| – | – | 0.05% | 94 |
|
|
2026
Q1 | $251K | Hold |
4,000
| – | – | 0.08% | 75 |
|
|
2025
Q4 | $381K | Hold |
4,000
| – | – | 0.12% | 67 |
|
|
2025
Q3 | $391K | Hold |
4,000
| – | – | 0.12% | 66 |
|
|
2025
Q2 | $430K | Hold |
4,000
| – | – | 0.15% | 55 |
|
|
2025
Q1 | $404K | Hold |
4,000
| – | – | 0.15% | 56 |
|
|
2024
Q4 | $357K | Hold |
4,000
| – | – | 0.13% | 64 |
|
|
2024
Q3 | $335K | Hold |
4,000
| – | – | 0.12% | 66 |
|
|
2024
Q2 | $308K | Hold |
4,000
| – | – | 0.11% | 68 |
|
|
2024
Q1 | $274K | Hold |
4,000
| – | – | 0.1% | 75 |
|
|
2023
Q4 | $231K | Sell |
4,000
-18
| -0.4% | -$961 | 0.09% | 78 |
|
|
2023
Q3 | $212K | Hold |
4,018
| – | – | 0.09% | 86 |
|
|
2023
Q2 | $217K | Hold |
4,018
| – | – | 0.09% | 84 |
|
|
2023
Q1 | $201K | Buy |
4,018
+18
| +0.5% | +$848 | 0.09% | 97 |
|
|
2022
Q4 | $185K | Sell |
4,000
-94
| -2% | -$4.07K | 0.09% | 90 |
|
|
2022
Q3 | $159K | Hold |
4,094
| – | – | 0.08% | 89 |
|
|
2022
Q2 | $153K | Hold |
4,094
| – | – | 0.08% | 93 |
|
|
2022
Q1 | $181K | Hold |
4,094
| – | – | 0.08% | 90 |
|
|
2021
Q4 | $174K | Hold |
4,094
| – | – | 0.08% | 93 |
|
|
2021
Q3 | $178K | Hold |
4,094
| – | – | 0.08% | 91 |
|
|
2021
Q2 | $175K | Buy |
4,094
+4,000
| +4,255% | +$168K | 0.08% | 94 |
|
|
2021
Q1 | $4K | Hold |
94
| – | – | ﹤0.01% | 211 |
|
|
2020
Q4 | $3K | Hold |
94
| – | – | ﹤0.01% | 206 |
|
|
2020
Q3 | $4K | Hold |
94
| – | – | ﹤0.01% | 192 |
|
|
2020
Q2 | $3K | Hold |
94
| – | – | ﹤0.01% | 233 |
|
|
2020
Q1 | $3K | Hold |
94
| – | – | ﹤0.01% | 206 |
|
|
2019
Q4 | $4K | Hold |
94
| – | – | ﹤0.01% | 219 |
|
|
2019
Q3 | $4K | Hold |
94
| – | – | ﹤0.01% | 206 |
|
|
2019
Q2 | $4K | Hold |
94
| – | – | ﹤0.01% | 198 |
|
|
2019
Q1 | $4K | Hold |
94
| – | – | ﹤0.01% | 191 |
|
|
2018
Q4 | $3K | Hold |
94
| – | – | ﹤0.01% | 196 |
|
|
2018
Q3 | $4K | Hold |
94
| – | – | ﹤0.01% | 181 |
|
|
2018
Q2 | $3K | Buy |
94
+61
| +185% | +$1.84K | ﹤0.01% | 237 |
|
|
2018
Q1 | $1K | Buy |
+33
| New | +$897 | ﹤0.01% | 225 |
|
Other funds holding BSX
Centerpoint Advisors's BSX Position: Q2 2026 in Review
Centerpoint Advisors held its Boston Scientific (BSX) position steady in Q2 2026 at 4,000 shares worth $171K. The position accounts for 0.05% of the portfolio, ranked #94.
Centerpoint Advisors first reported a position in BSX in Q1 2018 and has held it in 34 quarters since. The position peaked at $430K in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Centerpoint Advisors held 4,000 shares of Boston Scientific worth $171K as of Q2 2026.
- Centerpoint Advisors left its Boston Scientific share count unchanged in Q2 2026.
- Boston Scientific made up 0.05% of Centerpoint Advisors's portfolio in Q2 2026, its #94 holding.
- Centerpoint Advisors first reported a position in Boston Scientific in Q1 2018 and has held it in 34 quarters since.
- Centerpoint Advisors's Boston Scientific position peaked at $430K in Q2 2025.
- 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Centerpoint Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.